Cargando…
Plasma P-selectin is an early marker of thromboembolism in COVID-19
Coagulopathy and thromboembolism are known complications of SARS-CoV-2 infection. The mechanisms of COVID-19-associated hematologic complications involve endothelial cell and platelet dysfunction and have been intensively studied. We leveraged a prospectively collected acute COVID-19 biorepository t...
Autores principales: | Fenyves, Bánk G., Mehta, Arnav, Kays, Kyle R., Goldberg, Marcia B., Hacohen, Nir, Filbin, Michael R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8288158/ https://www.ncbi.nlm.nih.gov/pubmed/34282425 http://dx.doi.org/10.1101/2021.07.10.21260293 |
Ejemplares similares
-
Plasma P-selectin is an early marker of thromboembolism in COVID-19
por: Mehta, Arnav, et al.
Publicado: (2023) -
Plasma P‐selectin is an early marker of thromboembolism in COVID‐19
por: Fenyves, Bánk G., et al.
Publicado: (2021) -
Reply to Akin et al.: High Renin Concentrations in Severe COVID-19 Are Indicative for a Hypo–Renin–Angiotensin-System State
por: Leisman, Daniel E., et al.
Publicado: (2022) -
Vasopressin infusion in COVID-19 critical illness is not associated with impaired viral clearance: a pilot study
por: Leisman, Daniel E., et al.
Publicado: (2021) -
Plasma from patients with bacterial sepsis or severe COVID-19 induces suppressive myeloid cell production from hematopoietic progenitors in vitro
por: Reyes, Miguel, et al.
Publicado: (2021)